Solve compliance problems, lower costs & reduce risk with trusted consulting and training to streamline
FDA compliance & strengthen your bottom line.
Find out how →
The first newsletter exclusively devoted to FDA, ICH and IMDRF compliance best practices, quality system advice, actionable regulatory intelligence, and cutting-edge product development strategies for biotechnology, pharmaceutical, and medical device executives.
"This should be mandatory reading for industry executives"
- Dan Michels, former FDA inspector
Medical device manufacturers saw an increase in 2013 in the number FDA-483 observations that cite inadequate supplier controls. Poor supplier control is one of the top five most common 483 citations for devicemakers, and is an issue that has been gaining steam with FDA investigators and EMA inspectors for years. In 2010, 84 FDA-483 citations […]